Perpetual Medicines Raises $8M in Seed Round for Peptide Drug Discovery Platform

Perpetual Medicines  announced it has closed an $8 million seed financing to advance its integrated computational design and synthesis platform for pe...

December 04, 2023 | Monday | News
Route 92 Medical Secures $31M in Series F Funding to Boost Expansion in Growing Stroke Treatment Market

The oversubscribed capital raise was led by existing venture capital investors: U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners, and...

November 17, 2023 | Friday | News
£14.5 Million Funding Boost for Neurodegenerative Research Projects in the UK

Seven major research projects to receive more than £14 million to develop new tests, treatments and devices for neurodegenerative diseases includin...

November 14, 2023 | Tuesday | News
Singapore's Engine Biosciences Secures $27M in Series A Extension for Precision Oncology Development and Biomarker Research

Funds to support translation of R&D programs derived from proprietary NetMAPPR machine learning network biology platform and CombiGEM combinatorial gen...

November 02, 2023 | Thursday | News
Government of Serbia and Ginkgo Bioworks Announce Bioeconomy Collaboration in BIO4 Campus

Under the planned partnership, Ginkgo and the Serbian Ministry of Science, Technological Development and Innovation will work to establish a Startup Accele...

October 23, 2023 | Monday | News
Gero Secures $6M to Unlock Aging's Secrets with Physics-Powered GenAI Biotech"

Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding round positions Gero to con...

October 19, 2023 | Thursday | News
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million

“Our ongoing partnership with Bayer leverages the full suite of our Twist Biopharma Solutions offering of antibody discovery services to identify the...

October 06, 2023 | Friday | News
Debiopharm Innovation Fund Launches Seed Funding for Cancer Care Digital Transformation

--Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management,  announc...

September 29, 2023 | Friday | News
Evozyne Raises $81M for AI-Driven Drug Discovery

Evozyne announced the closing of an $81 million Series B investment round that will fund the biotech’s generative AI-powered drug discovery platform ...

September 28, 2023 | Thursday | News
National Institute of Health to Fund Preclinical Development of Trethera Lead Drug, TRE-515, for Treatment of Crohn’s Disease

Trethera Corporation, a clinical stage biopharmaceutical company committed to developing novel drugs targeting nucleotide metabolism for the treatment of c...

September 26, 2023 | Tuesday | News
BrainScope Receives Investment from the Alzheimer’s Drug Discovery Foundation for Alzheimer's Prediction Biomarker

-Brain diagnostics innovator BrainScope announced  a new investment from the Alzheimer’s Drug Discovery Foundation (ADDF) in BrainScope’s ...

September 20, 2023 | Wednesday | News
Vipragen Biosciences, India, Receives Second Investment from Karnataka Government's Fund

"We are thrilled to receive this investment from KITVEN and Conscience Multi Family Office," said Dr. Chandrashekaran. "This funding will empower us to f...

August 29, 2023 | Tuesday | News
Cellares Raises $255M Series C to Launch Pioneering Cell Therapy Smart Factory

Series C is led by Koch Disruptive Technologies and includes Bristol Myers Squibb, DFJ Growth, Willett Advisors and existing investors Eclipse, Dech...

August 24, 2023 | Thursday | News
Zetagen Raises $9.79M Series B for ZetaMet™ and ZetaMAST™ in Metastatic Lesion Treatment

ZetaMet™ is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone. ZetaMet™ is presently i...

August 14, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in